Nate Massari and Topher Brooke, with Aytu BioPharma, along with Hal Dietz, MD, will provide a brief background on the research leading up to the upcoming clinical trial for AR101 (Enzastaurin) for VEDS, and answer questions about steps in planning the trial and possible timeline.
Hear the latest in Marfan research from leading investigators and ask your questions via chat.
Ask your questions via chat to the scientists involved in genetics, bone, hearing, and tooth development research. Please view pre-recorded video before attending live Q and A session.
Learn about a new laser treatment to prevent retinal detachment and prevent blindness in Stickler syndrome.